Future advances in melanoma research

Clinics in Plastic Surgery
Thomas J Hornyak

Abstract

The future of melanoma research is promising. Specific mechanisms leading to oncogenic transformation in melanoma development have been identified, and are likely to produce new targets for melanoma therapy. Also, advances in melanoma research will result from melanoma investigators co-opting approaches used to study other malignancies in which progress has been made more rapidly. Systematic roadblocks limiting advances in melanoma research relative to other malignancies are being addressed in a formal manner. The public and public officials are increasingly becoming aware of the need for more dedicated efforts to address the challenges of research on this malignancy.

References

Mar 15, 1987·International Journal of Cancer. Journal International Du Cancer·D C BennettI R Hart
Sep 1, 1994·Nature Genetics·C J HussussianN C Dracopoli
Nov 14, 1997·Genes & Development·L ChinR A DePinho
Sep 12, 2000·The American Journal of Pathology·B C BastianD Pinkel
Aug 14, 2001·American Journal of Human Genetics·N F BoxN K Hayward
Sep 21, 2001·Nature·F P NoonanG Merlino
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Oct 28, 2003·The American Journal of Pathology·Boris C BastianDaniel Pinkel
Nov 18, 2003·Annual Review of Genetics·Jonathan L Rees
Dec 18, 2003·Journal of the National Cancer Institute·Janet L MaldonadoBoris C Bastian
Mar 11, 2004·The Journal of Investigative Dermatology·Hensin TsaoFrank G Haluska
Mar 16, 2004·Science·Yardena SamuelsVictor E Velculescu
Apr 3, 2004·Cancer Research·Claudia WellbrockRichard Marais
Nov 19, 2004·The New England Journal of Medicine·Sandeep S DaveLouis M Staudt
May 19, 2005·Cancer Research·Natasha Y FrankMarkus H Frank
Jun 14, 2005·Cancer Cell·Yardena SamuelsVictor E Velculescu
Aug 5, 2005·Nature·Chrysiis MichaloglouDaniel S Peeper
Aug 12, 2005·Nature·D Williams ParsonsVictor E Velculescu
Oct 19, 2005·Cancer Research·Dong FangMeenhard Herlyn
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Apr 6, 2006·Journal of the National Cancer Institute·Véronique WinnepenninckxUNKNOWN Melanoma Group of the European Organization for Research and Treatment of Cancer
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John A CurtinBoris C Bastian
Aug 17, 2006·Genes & Development·Lynda ChinDavid E Fisher
Sep 2, 2006·Science·Richard A MorganSteven A Rosenberg
Oct 19, 2006·Cancer Research·Alisa M GoldsteinUNKNOWN Melanoma Genetics Consortium (GenoMEL)
Feb 27, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elena MonzaniCaterina A M La Porta
Aug 2, 2007·Nature Reviews. Molecular Cell Biology·Judith Campisi, Fabrizio d'Adda di Fagagna
Nov 21, 2007·Expert Review of Anticancer Therapy·Véronique Winnepenninckx, Joost J van den Oord
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Stephen HodiDavid E Fisher
May 31, 2008·Pigment Cell & Melanoma Research·Jose LutzkyBoris C Bastian
Jul 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John M KirkwoodHelen J Gogas
Jul 22, 2008·Journal of the American Academy of Dermatology·Michael J MurphyHanspaul Makkar
Mar 31, 2009·Nature Genetics·Lavanya H PalavalliYardena Samuels

❮ Previous
Next ❯

Citations

Aug 30, 2013·Plastic and Reconstructive Surgery·William W Dzwierzynski
Jul 18, 2012·Dermatologic Clinics·Clay J Cockerell
Jul 17, 2010·Journal of the American Academy of Dermatology·Jacqueline M Junkins-Hopkins
Nov 5, 2010·Current Opinion in Supportive and Palliative Care

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

The New England Journal of Medicine
John A CurtinBoris C Bastian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Charles M BalchVernon K Sondak
© 2022 Meta ULC. All rights reserved